Table 2.
Patient and tumor characteristics
| Ref. | Patients | Stage | Median GTV size (cm3); mean (range) | Site | Median follow-up (mo), range |
| Koong et al[17], 2004 | 15 | NR | 29 (19-72) | H: 66.6%, B: 26.6%, T: 6.6% | 5.0 |
| Koong et al[18], 2005 | 191 | NR | 50 (14-92) | H: 68%, B: 32% | 5.4 |
| Schellenberg et al[19], 2008 | 16 | NR | PTV: 48 (21-84) | H: 87.5%, B: 12.5% | NR |
| Seo et al[20], 2009 | 30 | T4: 100.0% N1: 30.0% | 41 (21-96) | H: 56.7% B/T: 43.3% | 14.5 |
| Goyal et al[21], 2012 | 19 | M1: 4 pts | 57 (10-118) | NR | 9 (5.8-23.1) |
1
Sixteen patients received RRS. B: Body of the pancreas; H: Head of the pancreas; NR: Not reported; PTV: Planning target volume; T: Tail of the pancreas.